1)Eric JC, Campbell RJ, Lieseganng TJ:Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 93:176-183, 1986
2)Lee GA, Williams G, Hirst LW et al:Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 101:360-364, 1994
3)有澤武士・成田 信・堀田一樹・他:マイトマイシンCの点眼抵抗性の結膜上皮内癌に5-フルオロウラシル点眼が有効であった1例.臨眼 60:571-575,2006
4)鈴村幸史・鈴木久晴・高橋 浩・他:マイトマイシンCの点眼療法が著効した再発角結膜上皮内癌の1症例.眼臨 99:988-991,2005
5)敷島敬悟・水戸岡克哉・佐野雄太・他:角結膜上皮内癌に対する5フルオロウラシルのパルス点眼療法の有効性.臨眼 61:1001-1005,2007
6)Franke WW, Schmid E, Osborn M et al:Intermediate-sized filaments of human endothelial cells. J Cell Biol 81:570-580, 1979
7)Kato N, Shimmura S, Kawakita T et al:Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci 48:1511-1517, 2007
8)Border WA, Noble NA:Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
9)五十嵐俊彦:食道粘膜基底細胞過形成の免疫組織学的同定―食道癌の粘膜内進展・上皮内癌との鑑別への応用.新潟県厚生連医誌 17:91-92,2008
10)Stewart CJ, Little L:Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium. Pathology 42:217-223, 2010